Rick Santorum came surprisingly close to an upset in Wisconsin this week, losing to Mitt Romney by less than 5 percentage points. It was not as heartbreakingly close as his previous losses in Michigan and Ohio, but it was one more reminder of what might have been.
With a win in Wisconsin, Santorum would have confounded the ruling media narrative of the moment, which wants to turn from the primary season of spring to the autumnal matchup of Romney and President Obama.
Hearing about golf these past couple of years has turned into some sort of dual universe. On the one hand there is the real world, like: "Smith and Jones Tied for Lead in Cat Food Open."
But then, in more detail, the larger shadow story reads: "Tiger's Putter Falters, Trails By 12 Strokes."
Golf has become like fantasy football or Rotisserie Baseball. Only, imagine if everybody has the same guy — Tiger Woods — on his team. No other golfers seem to exist, except possibly The Ghost of Jack Nicklaus.
The scandal involving the General Services Administration's by now infamous conference featuring spending on a clown and mind reader is certainly far from the biggest in terms of the overall dollars involved. After all, we're talking about less than $1 million all told.
That's pocket change at the Pentagon, where they can probably find more taxpayer money under the couch cushions.
But it may go down in history as one of the dumbest. A clown and a mind reader at a conference of federal bureaucrats? Really?
Historically, young people have been much less likely to vote than older Americans.
That trend has started to change in the past few presidential election cycles, especially in 2008, when a census report found that 49 percent of those ages 18 to 24 who were eligible to vote participated in the presidential election.
A nonprofit foundation set up to support scientific research of interest to the Food and Drug Administration is finally starting to take off after years of struggling financially — and it's about to get some long-promised funding from the FDA.
But some critics worry that this foundation, which will also raise money from private sources including industry, could provide a way for the food and medical industries to sway FDA decisions.